Condition 1: diarrhea. Condition 2: nausea and vomiting. Diarrhea, unspecified Nausea with vomiting, unspecified
Conditions
Interventions
Placebo
Intervention 1: Intervention group: For patients in the intervention group, lactocare capsules will be administered at a dose of 500 mg per day for 14 days. Intervention 2: Control group: For patients
Treatment - Drugs
Intervention group: For patients in the intervention group, lactocare capsules will be administered at a dose of 500 mg per day for 14 days.
Control group: For patients in the control group, a placebo is prescribed for 14 days.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: 5 to 18 years of age both gender desire to participate in the study Lack cardiovascular diseases, AIDS, renal failure, diabetes
Exclusion criteria
Exclusion criteria: Diarrhea at the start of the study and before starting the drug Do not use the medication properly during the study period Unwilling to participate in the study Immune deficiency and cardiovascular disease, AIDS, renal failure, diabetes Patients with Grade 4 Nausea and vomiting
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: At the beginning of the study, on the seventh day and on the fourteenth day. Method of measurement: Recorded in checklist.;Diarrhea. Timepoint: At the beginning of the study, on the seventh day and on the fourteenth day. Method of measurement: Recorded in checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAziz Eghbali
Arak University of Medical Sciences
Outcome results
None listed